Oruka Therapeutics, Inc. ORKA Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s unrecognized tax benefits increases resulting from current period tax positions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s unrecognized tax benefits increases resulting from current period tax positions?
- Oruka Therapeutics, Inc. (ORKA) reported unrecognized tax benefits increases resulting from current period tax positions of $223.75K in Q4 2025.
- How has Oruka Therapeutics, Inc.'s unrecognized tax benefits increases resulting from current period tax positions changed year-over-year?
- Oruka Therapeutics, Inc.'s unrecognized tax benefits increases resulting from current period tax positions decreased by 78.6% year-over-year, from $1.05M to $223.75K.
- What does unrecognized tax benefits increases resulting from current period tax positions mean?
- Represents the gross increase in unrecognized tax benefits resulting from tax positions taken during the current reporting period. This metric reflects the company's assessment of uncertainty regarding the sustainability of new tax filings or positions. It is a key indicator of potential future tax liabilities and the company's conservative or aggressive approach to tax planning.